A multidisciplinary discussion of BladderPath
Can Urol Assoc J
.
2024 Mar;18(3):E91-E92.
doi: 10.5489/cuaj.8525.
Authors
Marie-Pier St-Laurent
1
,
John P Sfakianos
2
,
Tracy L Rose
3
,
Peter Chung
4
,
Wassim Kassouf
5
,
Alexandre R Zlotta
6
,
Brant Inman
7
,
Peter C Black
1
Affiliations
1
Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
2
Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
3
Division of Oncology, Department of Medicine, Lineberger comprehensive cancer, chapel Hill, NC, United States.
4
Center, University of North Carolina at chapel Hill, chapel Hill, NC, United States.
5
Department of Radiation Oncology, University of Toronto, Princess Margaret cancer center, Toronto, ON, Canada.
6
Department of Surgery, McGill University, McGill University Health center, Montreal, QC, Canada.
7
Division of Urology, Department of Surgery, University of Toronto, Mount Sinai, Toronto, ON, Canada.
PMID:
38010224
PMCID:
PMC10954283
DOI:
10.5489/cuaj.8525
No abstract available